Emily Kuiper is a driven scientist currently serving as the Associate Director at AvenCell, where they lead a research team focused on developing allogenic cell therapies for cancer. With a Ph.D. in Biochemistry and Structural Biology from Emory University, Emily has a strong background in creating innovative therapies for immune-oncology. Previously, they held positions at notable organizations such as bluebird bio and Dana-Farber Cancer Institute, where they advanced CAR T cell therapy programs and conducted significant research on solid tumors. Throughout their career, Emily has demonstrated a commitment to mentoring students and enhancing laboratory processes.
This person is not in any teams
This person is not in any offices